Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2749-2753

  Caron, François ^a,b,c   Gold, Howard S ^a,b   Wennersten, Christine B ^a   Farris, Michael G ^a   Moellering Jr , Robert C ^a,b   Eliopoulos, George M ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN; STREPTOGRAMIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONCENTRATION RESPONSE; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030833031     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2749     Document Type: Article

References (37)

1. Aumercier, M., S. Bouhallab, M. L. Capmau, and F. Le Goffic. 1992. RP 59500: a proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother. 30(Suppl. A):9-14.
2. Berthaud, N., A. M. Gouin, J. Rousseau, and J. F. Desnottes. 1993. RP 59500: killing kinetics against Gram-positive cocci in an in vitro pharmacokinetic model, abstr. 1048. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Bouanchaud, D. H. 1992. In-vitro and in-vivo synergistic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500. J. Antimicrob. Chemother. 30(Suppl. A):95-99.
4. Bouanchaud, D. H. 1997. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin. J. Antimicrob. Chemother. 39(Suppl. A):15-21.
5. Brumfitt, W., J. Hamilton-Miller, and S. Shah. 1992. In-vitro activity of RP 59500, a new semi-synthetic streptogramin antibiotic, against Gram-positive bacteria. J. Antimicrob. Chemother. 30(Suppl. A):29-37.
6. Caron, F., H. S. Gold, C. B. Wennersten, R. C. Moellering, Jr., and G. M. Eliopoulos. 1996. Role of growth phase and erythromycin susceptibility in the bactericidal effect of RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant Enterococcits faecium, p. 8-9. In Abstracts of the 3rd International Conference on Macrolides, Azalides and Streptogramins.
7. Casewell, H. R., M. Seyed-Akhavani, and J. Wade. 1993. In vitro activity of RP 59500 against vancomycin-resistant Enterococcus faecium also resistant to >512 mg/L of gentamicin, abstr. 1058. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Collins, L. A., G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, and R. C. Moellering, Jr. 1993. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37:598-601.
9. Entenza, J. M., H. Drugeon, M. P. Glauser, and P. Moreillon. 1995. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrob. Agents Chemother. 39:1419-1424.
10. Etienne, S. D., G. Montay, A. Le Liboux, A. Frydman, and J. J. Garaud. 1992. A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. J. Antimicrob. Chemother. 30(Suppl. A):121-131.
11. Fantin, B., R. Leclercq, L. Garry, and C. Carbon. 1997. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob. Agents Chemother. 41:931-935.
12. Fantin, B., R. Leclercq, Y. Merlé, L. Saint-Julien, C. Veyrat, J. Duval, and C. Carbon. 1995. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 39:400-405.
13. Fass, R. J. 1991. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob. Agents Chemother. 35:553-559.
14. Freeman, C., A. Robinson, B. Cooper, M. Mazens-Sullivan, R. Quintiliani, and C. Nightingale. 1995. In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn. Microbiol. Infect. Dis. 21:47-50.
15. Fremaux, A., G. Sissia, R. Cohen, and P. Geslin. 1992. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae. J. Antimicrob. Chemother. 30(Suppl. A):19-23.
16. Gold, H. S., S. Unal, E. Cercenado, C. Thauvin-Eliopoulos, C. B. Wennersten, and R. C. Moellering, Jr. 1993. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob. Agents Chemother. 37:1604-1609.
17. Goto, S., S. Miyazaki, and Y. Kaneko. 1992. The in-vitro activity of RF 59500 against gram-positive cocci. J. Antimicrob. Chemother. 30(Suppl. A):25-28.
18. Handwerger, S., M. J. Pucci, and A. Kolokathis. 1990. Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob. Agents Chemother. 34:358-360.
19. Hill, R. L. R., C. Smith, and M. W. Casewell. 1995. Bactericidal and inhibitory activity of RP 59500 (quinupristin/dalfopristin) and its components against vancomycin- and gentamicin-resistant Enterococcus faecium, abstr. E118, p. 106. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Johnson, C. C., L. Slavoski, M. Schwartz, P. May, P. G. Pitsakis, A. L. Shur, and M. E. Levison. 1995. In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci. Diagn. Microbiol. Infect. Dis. 21:169-173.
21. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anderson, and The Enterococcus Study Group. 1995. Emerging multiply resistant enterococci (MRE) among clinical isolates: prevalence data from 97 medical centers. Diagn. Microbiol. Infect. Dis. 21:85-93.
22. Kang, S. L., and M. J. Rybak. 1995. In vitro bactericidal activity of RP 59500 (quinupristin/dalfopristin; RP) alone and in combinations against resistant strains of Enterococcus species and Staphylococcus aureus (SA), abstr. E121, p. 107. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Leclercq, R., L. Nantas, C. J. Soussy, and J. Duval. 1992. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. J. Antimicrob. Chemother. 30(Suppl. A):67-75.
24. L'Hériteau, F., J. M. Entenza, F. Lacassin, C. Leport, M. P. Glauser, and P. Moreillon. 1995. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrob. Agents Chemother. 39:1425-1428.
25. Mahayni, R., M. B. Perri, L. M. Dembry, and M. J. Zevros. 1994. Comparative in-vivo and bactericidal activity of RP 59500 (quinupristin/dalfopristin) against multi-drug resistant E. faecinm, abstr. E3, p. 27. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. National Committee for Clinical Laboratory Standards. 1987. Methods for determining bactericidal activity of antimicrobial agents: proposed guideline. M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
28. Nougayrede, A., N. Berthaud, and D. H. Bouanchaud. 1992. Post-antibiotic effects of RP 59500 with Staphylococcus aureus. J. Antimicrob. Chemother. 30(Suppl. A):101-106.
29. Pankuch, G. A., C. Lichtenberger, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococeal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob. Agents Chemother. 40:1653-1656.
30. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
31. Rende-Fournier, R., R. Leclercq, M. Galimand, J. Duval, and P. Courvalin. 1993. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob. Agents Chemother. 37:2119-2125.
32. Rosato, A., H. Vicarini, and R. Leclercq. 1996. High-level cross-resistance to macrolides and lincosamides in streptococci and enterococci: constitutive or inducible expression of ribosomal methylase?, abstr. C81, p. 49. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 1.98-1.99. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Soussy, C. J., J. F. Acar, R. Cluzel, P. Courvalin, J. Duval, J. Fleurette, F. Megraud, M. Meyran, and A. Thabaut. 1992. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J. Antimicrob. Chemother. 30(Suppl. A):53-58.
35. Steers, D., E. L. Foltz, B. S. Gravies, and J. Rindel. 1959. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. (Basel) 9:307-311.
36. Tenover, F. C., and C. N. Baker. 1995. Development of provisional disk diffusion breakpoint for testing RP 59500 (quinupristin/dalfopristin): an injectable streptogramin, abstr. D30, p. 71. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
37. Williams, J. D., J. P. Maskell, A. C. Whiley, and A. M. Sefton. 1997. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J. Antimicrob. Chemother. 39(Suppl. A):41-46.